Replimune Group, Inc.
REPL
$11.66
-$0.205-1.73%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/13/2025
-
MarketBeat
3/12/2025
-
Tickeron - Stocks
3/8/2025
-
Tickeron - Stocks
3/7/2025
-
Globe Newswire
3/4/2025
-
Tickeron - Stocks
3/1/2025
-
Tickeron - Stocks
2/28/2025
-
Tickeron - Stocks
2/28/2025
-
Tickeron - Stocks
2/26/2025
-
MarketBeat
2/26/2025
-
Tickeron - Stocks
2/22/2025
-
Ticker Report
2/21/2025
-
MarketBeat
2/21/2025
-
Tickeron - Technical Analysis
2/20/2025
-
Ticker Report
2/20/2025
-
MarketBeat
2/20/2025
-
Tickeron - Stocks
2/19/2025
-
Tickeron - Stocks
2/17/2025
-
Simply Wall St
2/17/2025
-
MarketBeat
2/17/2025
-
MarketBeat
2/17/2025
-
MarketBeat
2/15/2025
-
Tickeron - Stocks
2/15/2025
-
Tickeron - Stocks
2/14/2025
-
MarketBeat
2/14/2025
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, February 12, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
781 222 9600
Address
500 Unicorn Park Drive
Woburn, MA 01801
Woburn, MA 01801
Country
Year Founded
Business Description
Sector
Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The company’s proprietary tumor-directed oncolytic...
more